Your search returned 9 results.

Results
	1.	Psychoneuroimmunology in oral biology and medicine: the model of oral lichen planus. [electronic resource] by Prolo, Paolo Chiappelli, Francesco Cajulis, Elaina Bauer, Janet Spackman, Susan Romeo, Horacio Carrozzo, Marco Gandolfo, Sergio Christensen, Russell Producer: 20020815 In: Annals of the New York Academy of Sciences vol. 966 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Efficacy of ganitumab (AMG 479), alone and in combination with rapamycin, in Ewing's and osteogenic sarcoma models. [electronic resource] by Beltran, Pedro J Chung, Young-Ah Moody, Gordon Mitchell, Petia Cajulis, Elaina Vonderfecht, Steven Kendall, Richard Radinsky, Robert Calzone, Frank J Producer: 20110719 In: The Journal of pharmacology and experimental therapeutics vol. 337 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	IGF1R blockade with ganitumab results in systemic effects on the GH-IGF axis in mice. [electronic resource] by Moody, Gordon Beltran, Pedro J Mitchell, Petia Cajulis, Elaina Chung, Young-Ah Hwang, David Kendall, Richard Radinsky, Robert Cohen, Pinchas Calzone, Frank J Producer: 20140512 In: The Journal of endocrinology vol. 221 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	HER-2 overexpression differentially alters transforming growth factor-beta responses in luminal versus mesenchymal human breast cancer cells. [electronic resource] by Wilson, Cindy A Cajulis, Elaina E Green, Jennifer L Olsen, Taylor M Chung, Young Ah Damore, Michael A Dering, Judy Calzone, Frank J Slamon, Dennis J Producer: 20060227 In: Breast cancer research : BCR vol. 7 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5.	Epitope-specific mechanisms of IGF1R inhibition by ganitumab. [electronic resource] by Calzone, Frank J Cajulis, Elaina Chung, Young-Ah Tsai, Mei-Mei Mitchell, Petia Lu, John Chen, Ching Sun, Jilin Radinsky, Robert Kendall, Richard Beltran, Pedro J Producer: 20130715 In: PloS one vol. 8 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	6.	MAPK pathway inhibition induces MET and GAB1 levels, priming BRAF mutant melanoma for rescue by hepatocyte growth factor. [electronic resource] by Caenepeel, Sean Cooke, Keegan Wadsworth, Sarah Huang, Guo Robert, Lidia Moreno, Blanca Homet Parisi, Giulia Cajulis, Elaina Kendall, Richard Beltran, Pedro Ribas, Antoni Coxon, Angela Hughes, Paul E Producer: 20170907 In: Oncotarget vol. 8 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	7.	AMG 479, a fully human anti-insulin-like growth factor receptor type I monoclonal antibody, inhibits the growth and survival of pancreatic carcinoma cells. [electronic resource] by Beltran, Pedro J Mitchell, Petia Chung, Young-A Cajulis, Elaina Lu, John Belmontes, Brian Ho, Joanne Tsai, Mei Mei Zhu, Min Vonderfecht, Steven Baserga, Renato Kendall, Richard Radinsky, Robert Calzone, Frank J Producer: 20111122 In: Molecular cancer therapeutics vol. 8 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	8.	Ganitumab (AMG 479) inhibits IGF-II-dependent ovarian cancer growth and potentiates platinum-based chemotherapy. [electronic resource] by Beltran, Pedro J Calzone, Frank J Mitchell, Petia Chung, Young-Ah Cajulis, Elaina Moody, Gordon Belmontes, Brian Li, Chi-Ming Vonderfecht, Steven Velculescu, Victor E Yang, Guorong Qi, Jingwei Slamon, Dennis J Konecny, Gottfried E Producer: 20150107 In: Clinical cancer research : an official journal of the American Association for Cancer Research vol. 20 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	9.	AMG 176, a Selective MCL1 Inhibitor, Is Effective in Hematologic Cancer Models Alone and in Combination with Established Therapies. [electronic resource] by Caenepeel, Sean Brown, Sean P Belmontes, Brian Moody, Gordon Keegan, Kathleen S Chui, Danny Whittington, Douglas A Huang, Xin Poppe, Leszek Cheng, Alan C Cardozo, Mario Houze, Jonathan Li, Yunxiao Lucas, Brian Paras, Nick A Wang, Xianghong Taygerly, Joshua P Vimolratana, Marc Zancanella, Manuel Zhu, Liusheng Cajulis, Elaina Osgood, Tao Sun, Jan Damon, Leah Egan, Regina K Greninger, Patricia McClanaghan, Joseph D Gong, Jianan Moujalled, Donia Pomilio, Giovanna Beltran, Pedro Benes, Cyril H Roberts, Andrew W Huang, David C Wei, Andrew Canon, Jude Coxon, Angela Hughes, Paul E Producer: 20191223 In: Cancer discovery vol. 8 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)